Protective Effects of Silymarin Against Age-Related Hearing Loss in an Aging Rat Model
- 51 Downloads
Age-related hearing loss (ARHL) is one of the most common chronic degenerative disorders. Several studies have indicated that supplementation with some antioxidants can slow down the progression of ARHL. Despite several lines of evidence about the potent antioxidant and anti-aging effects of silymarin, its protective effect against ARHL has not evaluated yet. The aim of the current study was to investigate the effects of silymarin in prevention of ARHL in a d-Galactose-induced aging rat model for the first time. 45 male wistar rats aged 3-month old were divided into 5 groups: group 1, 2 and 3 received 500 mg/kg/day d-Gal plus 100, 200 and 300 mg/kg/day silymarin respectively for 8 weeks, placebo group received 500 mg/kg/day d-Gal plus propylene glycol as placebo, and control group received normal saline during this period of time. Auditory brainstem responses were measured at several frequencies (4, 6, 8, 12 and 16 kHz) before and after the intervention. Placebo group and group 3 showed significant ABR threshold increase across frequencies of 4, 6, 16 kHz compared with the other groups (P < 0.05). However, rats treated with silymarin 100 and 200 mg/kg/day plus d-Gal did not show any significant ABR threshold shifts. Similarly, ABR amplitude of P2 at 4, 8 kHz and P1, P4 at 4 kHz in the placebo group and group 3 were decreased significantly compared with other groups (P < 0.05). However, no significant differences are found in ABR absolute and inter-peak latencies between groups (P > 0.05). The findings indicates that silymarin with doses of 100 and 200 mg/kg/day has protective effect against ARHL and it can be supplemented into the diet of older people to slow down the progression of age-related hearing loss.
KeywordsSilymarin Age-related hearing loss d-Galactose
This research has been supported by Tehran University of Medical Sciences. The authors would also like to thank Goldaru for supplying pure silymarin powder.
The article was supported by Tehran University of Medical Sciences.
Compliance with Ethical Standards
Conflict of interest
The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
- 5.Gates GA, Mills JH (2005) Lancet. Presbycusis 366(9491):1111–1120Google Scholar
- 29.Fetoni AR, De Bartolo P, Eramo SLM, Rolesi R, Paciello F, Bergamini CH, Fato R, Paludetti G, Petrosini L, Troiani D (2013) Noise-induced hearing loss (NIHL) as a target of oxidative stress-mediated damage: cochlear and cortical responses after an increase in antioxidant defense. J Neurosci 33(9):4011–4023CrossRefPubMedPubMedCentralGoogle Scholar
- 34.Neri S, Signorelli S, Pulvirenti D, Mauceri B, Cilio D, Bordonaro F, Abate G, Interlandi D, Misseri M, Ignaccolo L, Savastano M, Azzolina R, Grillo C, Messina A, Serra A, Tsami A (2006) Oxidative stress, nitric oxide, endothelial dysfunction and tinnitus. Free Radic Res 40(6):615–618CrossRefGoogle Scholar
- 40.Benkafadar N (2015) Oxidative stress: key mechanism of age-related cochlear sensory hair cell loss. J Int Soc Antioxid Nutr Health. Special issue for 15th international antioxidants congress, vol 1, no 1Google Scholar
- 50.Sanz-Fernández R, Sánchez-Rodriguez C, Granizo JJ, Durio-Calero E, Martín-Sanz E (2016) Accuracy of auditory steady state and auditory brainstem responses to detect the preventive effect of polyphenols on age-related hearing loss in Sprague–Dawley rats. Eur Arch Otorhinolaryngol 273(2):341–347CrossRefGoogle Scholar
- 70.Rasul A, Akhtar N, Ali Khan B, Mahmood T, Uz Zaman SH, Ali A et al (2011) Assessment of anti erythmic and skin whitening effects of milk thistle extract. Afr J Pharm Pharmacol 5(20):2306–2309Google Scholar
- 75.Najafzadeh H, Esmailzadeh S, Morovvati H, Avizeh R, Ezati M (2010) Protective effect of silymarin and vitamin E on gentamicin-induced pathological changes in kidney of dog. Iran J Med Aromat Plants 26(1):91–100Google Scholar
- 77.Zhu SY, Dong Y, Tu J, Zhou Y, Zhou XH, Bin Xu (2014) Silybum marianum oil attenuates oxidative stress and ameliorates mitochondrial dysfunction in mice treated with d-galactose. Pharmacogn Mag 10(1):92–99Google Scholar
- 84.Kong W, Hu Y, Wang Q, Xu L, Wang Y, Han Y, Li J, Liu B, Kong W (2006) Establishment of model with inner ear mimetic aging and mtDNA 4834 bp deletion in rats. J Clin Otolaryngol 20(19):888–890Google Scholar
- 88.Ghosh A, Ghosh T, Jain S (2010) Silymarin-a review on the pharmacodynamics and bioavailability enhancement approaches. J Pharm Sci Technol 2(10):348–355Google Scholar
- 90.Zarban A, Masood Z (2008) Evaluation of antioxidant properties of silymarin and its potential to inhibit peroxyl radicals in vitro. Pak J Pharm Sci 21(3):249–254Google Scholar
- 92.Hosny Mansour H, Farouk Hafez H, Mohamed FN (2006) Silymarin modulates cisplatin-induced oxidative stress and hepatotoxicity in rats. J Biochem Mol Biol 39(6):656–661Google Scholar
- 97.Saller R, Melzer J, Reichling J, Brignoli R, Meier R (2007) An updated systematic review of the pharmacology of silymarin. Forsch Komplementärmed 14:70–80Google Scholar
- 98.Sasu A, Herman H, Folk A, Baltǎ C, Roşu M, Miuţescu E et al (2016) Protective effects of silymarin on epirubicin-induced hepatotoxicity in mice. Studia Universitatis Vasile Goldiş Seria Ştiinţele Vieţi 26(3):305–316Google Scholar